Stereoselective Synthesis of [<scp>l</scp>-Arg-<scp>l</scp>/<scp>d</scp>-3-(2-naphthyl)alanine]-Type (<i>E</i>)-Alkene Dipeptide Isosteres and Its Application to the Synthesis and Biological Evaluation of Pseudopeptide Analogues of the CXCR4 Antagonist FC131

Hirokazu Tamamura(Tokyo Medical and Dental University), Kenichi Hiramatsu(St. Marianna University School of Medicine), Satoshi Ueda(St. Marianna University School of Medicine), Zixuan Wang(University of Louisville), Shuichi Kusano(University of Louisville), Shigemi Terakubo(Tokyo Medical and Dental University), John O. Trent(Tokyo Medical and Dental University), Stephen C. Peiper(St. Marianna University School of Medicine), Naoki Yamamoto(St. Marianna University School of Medicine), Hideki Nakashima(University of Louisville), Akira Otaka(University of Louisville), Nobutaka Fujii(University of Louisville)
Journal of Medicinal Chemistry
December 21, 2004
Cited by 92Open Access
Full Text

Abstract

L,L-Type and L,D-type (E)-alkene dipeptide isosteres (EADIs) that have unnatural side chains at the alpha-position were synthesized by the combination of stereoselective aziridinyl ring-opening reactions and organozinc-copper-mediated anti-S(N)2' reactions toward a single substrate of gamma,delta-cis-gamma,delta-epimino (E)-alpha,beta-enoate. The utility of this methodology was demonstrated by the stereoselective synthesis of a set of diastereomeric EADIs of L-Arg-L/D-3-(2-naphthyl)alanine (Nal) that is contained in a small CXCR4 antagonist FC131 [cyclo(-D-Tyr-Arg-Arg-Nal-Gly-)]. Furthermore, a (Nal-Gly)-type EADI was synthesized by samarium diiodide (SmI(2))-induced reduction of a gamma-acetoxy-alpha,beta-enoate. Several FC131 analogues, in which these EADIs were inserted for reduction of their peptide character, were synthesized with analogues containing reduced amide-type dipeptide isosteres to investigate the importance of these amide bonds for anti-HIV and CXCR4-antagonistic activity.


Related Papers

No related papers found

Powered by citation graph analysis